SCHEMBL8619696

SCHEMBL8619696

Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccccc2S(N)(=O)=O)cc1.O=S(=O)(Nn1nc(C(F)(F)F)c(Cl)c1-c1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 13/20 0.45
PDPK1 O15530 6/20 0.45
PTGS1 P23219 6/20 0.45
CYP2C9 P11712 2/20 0.45
PTGES O14684 1/20 0.45
HDAC3 O15379 1/20 0.45
CA12 O43570 1/20 0.45
PDE5A O76074 1/20 0.45
ABCB11 O95342 1/20 0.45
MT-CO2 P00403 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
LMNA P02545 1/20 0.45
CA3 P07451 1/20 0.45
CYP3A4 P08684 1/20 0.45
ALOX5 P09917 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
CYP2D6 P10635 1/20 0.45
ADRB3 P13945 1/20 0.45
ALOX15 P16050 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8163016 0.87 PTGS2 (0.41) PTGS2PDPK1PTGS1CYP2C9PTGES
Benzenesulfonamide SCHEMBL7051156 0.81 PTGS2 (0.60) PTGS2PDPK1PTGS1
SCHEMBL29502699 0.81 PTGS2 (0.66) PTGS2PDPK1PTGS1CYP2C9PTGES
SCHEMBL6912425 0.81 PTGS2 (0.66) PTGS2PDPK1PTGS1CYP2C9PTGES
SCHEMBL8639798 0.81 PTGS2 (0.66) PTGS2PDPK1PTGS1CYP2C9RXRA
SCHEMBL8204244 0.80 PTGS1 (0.51) PTGS2PTGS1LMNA
SCHEMBL7924378 0.78 PTGS2 (0.53) PTGS2PDPK1PTGS1RXRANR1H2
Benzenesulfonamide SCHEMBL7773919 0.76 PTGS2 (0.68) PTGS2PDPK1PTGS1
SCHEMBL8637676 0.76 PTGS2 (0.56) PTGS2PDPK1PTGS1CYP2C9PTGES
SCHEMBL8639018 0.75 PTGS2 (0.55) PTGS2PDPK1PTGS1RXRANR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998016227-A9 METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE TREATMENT AND PREVENTION OF NEOPLASIA 1998-07-30 WO disclosed